Lu Ai-Guo, Zhao Xue-wei, Mao Zhi-hai, Han Ding-pei, Zhao Jing-kun, Wang Puxiongzhi, Zhang Zhuo, Zong Ya-ping, Thasler Wolfgang, Feng Hao
1 Shanghai Minimally Invasive Surgical Center, Ruijin Hospital, Shanghai Jiaotong University School of Medicine , Shanghai, China .
J Laparoendosc Adv Surg Tech A. 2014 Nov;24(11):756-61. doi: 10.1089/lap.2014.0163.
This study investigated the impact of laparoscopic rectal cancer resection for patients with high operative risk, which was defined as American Society of Anesthesiology (ASA) grades III and IV. This study was conducted at a single center on patients undergoing rectal resection from 2006 to 2010. After screening by ASA grade III or IV, 248 patients who met the inclusion criteria were identified, involving 104 open and 144 laparoscopic rectal resections. The distribution of the Charlson Comorbidity Index was similar between the two groups. Compared with open rectal resection, laparoscopic resection had a significantly lower total complication rate (P<.0001), lower pain rate (P=.0002), and lower blood loss (P<.0001). It is notable that the two groups of patients had no significant difference in cardiac and pulmonary complication rates. Thus, these data showed that the laparoscopic group for rectal cancer could provide short-term outcomes similar to those of their open resection counterparts with high operative risk. The 5-year actuarial survival rates were 0.8361 and 0.8119 in the laparoscopic and open groups for stage I/II (difference not significant), as was the 5-year overall survival rate in stage III/IV (P=.0548). In patients with preoperative cardiovascular or pulmonary disease, the 5-year survival curves were significantly different (P=.0165 and P=.0210), respectively. The cost per patient did not differ between the two procedures. The results of this analysis demonstrate the potential advantages of laparoscopic rectal cancer resection for high-risk patients, although a randomized controlled trial should be conducted to confirm the findings of the present study.
本研究调查了腹腔镜直肠癌切除术对手术风险高的患者的影响,手术风险高定义为美国麻醉医师协会(ASA)III级和IV级。本研究在一个单一中心对2006年至2010年接受直肠切除术的患者进行。经ASA III级或IV级筛查后,确定了248例符合纳入标准的患者,其中104例行开放直肠切除术,144例行腹腔镜直肠切除术。两组患者的查尔森合并症指数分布相似。与开放直肠切除术相比,腹腔镜切除术的总并发症发生率显著更低(P<0.0001),疼痛发生率更低(P=0.0002),失血量更少(P<0.0001)。值得注意的是,两组患者的心肺并发症发生率无显著差异。因此,这些数据表明,对于手术风险高的患者,腹腔镜直肠癌切除术组的短期结局与开放切除术组相似。I/II期腹腔镜组和开放组的5年精算生存率分别为0.8361和0.8119(差异不显著),III/IV期的5年总生存率也是如此(P=0.0548)。在术前有心血管或肺部疾病的患者中,5年生存曲线有显著差异(分别为P=0.0165和P=0.0210)。两种手术方式的人均费用无差异。本分析结果显示了腹腔镜直肠癌切除术对高危患者的潜在优势,尽管应进行随机对照试验以证实本研究的结果。